News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Noven Pharmaceuticals Inc. Execs Got Bonuses Despite 2 Product Recalls
April 14, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BNET -- Noven rewarded its top managers with hundreds of thousands of dollars in bonuses last year despite the company’s flagship Daytrana ADHD patch being mired in two product recalls.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoffs
Genentech Downsizes by 87 as Priorities Shift
July 24, 2025
·
2 min read
·
Tristan Manalac
Obesity
Roche Drops Early Obesity Asset, Citing Lack of Competitiveness
July 24, 2025
·
2 min read
·
Tristan Manalac
Business
Maryland’s Life Sciences Scene Boasts Strong R&D, Manufacturing Talent
July 24, 2025
·
4 min read
·
Angela Gabriel
Startups
Dispatch Bio Launches With $216M To Develop Universal CAR T Therapy for Solid Tumors
July 23, 2025
·
2 min read
·
Tristan Manalac